COVID-19 and haemoglobin oxygen affinity: some clarity?
Br J Haematol
.
2020 Sep;190(5):723-724.
doi: 10.1111/bjh.17053.
Epub 2020 Aug 17.
Authors
Michael J Shattock
1
,
Yvonne Daniel
2
,
Beverley J Hunt
3
,
Andrew Retter
4
,
Katherine Henderson
5
,
Sarah Wilson
6
,
Claire C Sharpe
7
Affiliations
1
School of Cardiovascular Medicine and Sciences, King's College London, London, UK.
2
Public Health England, NHS Sickle Cell and Thalassaemia Screening Programme, London, UK.
3
Department of Haematology, GSTT, London, UK.
4
Department of Haematology, Guy's and Saint Thomas' Hospitals NHS Trust, London, UK.
5
Emergency Medicine, Guy's and Saint Thomas' NHS Foundation Trust Infection Service, London, UK.
6
Viapath Blood Sciences Laboratories, Guy's and Saint Thomas' Hospitals NHS Trust, London, UK.
7
Inflammation Biology, King's College London, London, UK.
PMID:
32805061
PMCID:
PMC7460983
DOI:
10.1111/bjh.17053
No abstract available
Keywords:
COVID-19 infection; allosteric modulators; haemoglobin oxygen.
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections*
Hemoglobins*
Humans
Oxygen
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Substances
Hemoglobins
Oxygen